Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine

NCT01778413 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Anna Cruceta